STOCKHOLM, Sweden--(BUSINESS WIRE)--Q-Med’s product SOLESTA has received a CE certification for the indication fecal incontinence. The approval is an important step in the development of the product and SOLESTA will be further documented together with leading colorectal surgeons in the field. This will be done through a product up-take and experience trial across Europe that will start this autumn. In parallel, Q-Med will continue its efforts to develop clinical data to support a US approval. Recently, the first patient was enrolled in the US/EU controlled study that is a corner stone for the US documentation.
